Outset Medical, Inc. (NASDAQ:OM) CFO Sells $10,401.04 in Stock

Outset Medical, Inc. (NASDAQ:OM) CFO Nabeel Ahmed sold 584 shares of the company’s stock in a transaction dated Thursday, May 15th. The stock was sold at an average price of $17.81, for a total transaction of $10,401.04. Following the completion of the transaction, the chief financial officer now owns 16,096 shares of the company’s stock, valued at approximately $286,669.76. This trade represents a 3.50% decrease in their position. The sale was disclosed in a document filed with the SEC, which is available at this hyperlink.

Outset Medical Price Performance

NASDAQ:OM opened at $19.50 on Monday. The stock has a 50 day moving average of $11.57 and a two-hundred day moving average of $12.84. Outset Medical, Inc. has a 12 month low of $5.85 and a 12 month high of $72.60. The firm has a market cap of $70.10 million, a P/E ratio of -7.86 and a beta of 1.90. The company has a current ratio of 6.49, a quick ratio of 5.04 and a debt-to-equity ratio of 4.12.

Outset Medical (NASDAQ:OM) last issued its quarterly earnings results on Wednesday, May 7th. The company reported ($3.66) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.97) by ($2.69). Outset Medical had a negative return on equity of 175.64% and a negative net margin of 112.57%. The firm had revenue of $29.75 million during the quarter, compared to analyst estimates of $27.81 million. On average, analysts expect that Outset Medical, Inc. will post -1.99 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Outset Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the business. Two Sigma Securities LLC grew its position in shares of Outset Medical by 190.0% in the fourth quarter. Two Sigma Securities LLC now owns 42,477 shares of the company’s stock valued at $47,000 after purchasing an additional 27,830 shares in the last quarter. XTX Topco Ltd acquired a new position in Outset Medical during the fourth quarter worth $50,000. TD Asset Management Inc purchased a new stake in Outset Medical in the 1st quarter valued at $589,000. Two Sigma Investments LP increased its stake in shares of Outset Medical by 36.0% in the 4th quarter. Two Sigma Investments LP now owns 488,602 shares of the company’s stock worth $542,000 after acquiring an additional 129,334 shares during the last quarter. Finally, Squarepoint Ops LLC purchased a new position in shares of Outset Medical during the 4th quarter worth $174,000.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on the stock. Royal Bank of Canada boosted their price target on shares of Outset Medical from $12.00 to $14.00 and gave the stock a “sector perform” rating in a report on Thursday, May 8th. Stifel Nicolaus set a $15.00 target price on shares of Outset Medical in a research report on Friday, March 21st.

About Outset Medical

Outset Medical, Inc, a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company offers Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables.